Review



windows version 25  (SPSS Inc)


Bioz Verified Symbol SPSS Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SPSS Inc windows version 25
    Windows Version 25, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/nct06069492-79-21-19?v=SPSS+Inc
    Average 90 stars, based on 1 article reviews
    windows version 25 - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    windows version 25  (SPSS Inc)
    90
    SPSS Inc windows version 25
    Windows Version 25, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/nct06069492-79-21-19?v=SPSS+Inc
    Average 90 stars, based on 1 article reviews
    windows version 25 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    hpa version 25 0  (Human Protein Atlas)
    86
    Human Protein Atlas hpa version 25 0
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Hpa Version 25 0, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/bio_rxiv__64898__2026__05__16__724529-139-14-11?v=Human+Protein+Atlas
    Average 86 stars, based on 1 article reviews
    hpa version 25 0 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    biovia version 25 1 0  (Accelrys)
    86
    Accelrys biovia version 25 1 0
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Biovia Version 25 1 0, supplied by Accelrys, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pm41874158-526-0-0?v=Accelrys
    Average 86 stars, based on 1 article reviews
    biovia version 25 1 0 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    compusense software version 25 0 21  (Compusense Inc)
    86
    Compusense Inc compusense software version 25 0 21
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Compusense Software Version 25 0 21, supplied by Compusense Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/10__3390_slash_pr14060904-112-5-9?v=Compusense+Inc
    Average 86 stars, based on 1 article reviews
    compusense software version 25 0 21 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    sequence alignment editor version 7 25  (Bioedit Company)
    86
    Bioedit Company sequence alignment editor version 7 25
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Sequence Alignment Editor Version 7 25, supplied by Bioedit Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pm41785633-108-9-8?v=Bioedit+Company
    Average 86 stars, based on 1 article reviews
    sequence alignment editor version 7 25 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    version 7 25 sequence editor  (Bioedit Company)
    86
    Bioedit Company version 7 25 sequence editor
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Version 7 25 Sequence Editor, supplied by Bioedit Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pmc12912582-75-17-16?v=Bioedit+Company
    Average 86 stars, based on 1 article reviews
    version 7 25 sequence editor - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    version 7 25 21 sequence editor  (Bioedit Company)
    86
    Bioedit Company version 7 25 21 sequence editor
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Version 7 25 21 Sequence Editor, supplied by Bioedit Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pm41701752-80-17-16?v=Bioedit+Company
    Average 86 stars, based on 1 article reviews
    version 7 25 21 sequence editor - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    simcyp version 25  (Certara L.P)
    86
    Certara L.P simcyp version 25
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Simcyp Version 25, supplied by Certara L.P, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pmc12944153-184-18-21?v=Certara+L.P
    Average 86 stars, based on 1 article reviews
    simcyp version 25 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    labsolutions software version 1 25 sp4  (Shimadzu Corporation)
    99
    Shimadzu Corporation labsolutions software version 1 25 sp4
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Labsolutions Software Version 1 25 Sp4, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pm41617261-106-5-10?v=Shimadzu+Corporation
    Average 99 stars, based on 1 article reviews
    labsolutions software version 1 25 sp4 - by Bioz Stars, 2026-06
    99/100 stars
    		  Buy from Supplier
    primer premier software version 6 25  (Premier Biosoft)
    86
    Premier Biosoft primer premier software version 6 25
    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.
    Primer Premier Software Version 6 25, supplied by Premier Biosoft, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/version+25/pm41442814-116-16-21?v=Premier+Biosoft
    Average 86 stars, based on 1 article reviews
    primer premier software version 6 25 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.

    Journal: bioRxiv

    Article Title: Epidermal growth factor (EGF) receptor family signalling in cardiomyocyte hypertrophy and heart failure

    doi: 10.64898/2026.05.16.724529

    Figure Lengend Snippet: A , Schematic of the EGFR family and the ligands that bind to them (left). Illustration of receptor homodimerization and heterodimerization that allows all EGFR family members to activate intracellular signalling, responding to, for example, EGF or NRG1 (right). Overexpression of receptors can also result in oligomerization and activation in the absence of ligand. B , mRNA expression of receptors (upper panel) and ligands (centre and lower panels) in each of 17 cell types (c-0 to c-17) identified in human heart tissue. Expression of the EGFR family (EGFR, ERBB2, ERBB3, ERBB4) is compared with the two receptors for endothelin-1 (EDNRA, EDNRB). Expression of EGFR family ligands (EGF, AREG, EREG, HBEGF, NRG1) is compared with expression of endothelin-1 (EDN1), an established agonist involved in cardiac hypertrophy . Data are from the Human Protein Atlas version 25.0. C-D , mRNA expression of endothelin and the EGFR family ( C ) and EGFR family ligands ( D ) in human failing hearts (HF) compared with non-failing hearts (NF). Statistical analysis used Mann-Whitney tests. p values for significant (p<0.05) changes are shown in bold type with values of 0.05-0.1 in standard type.

    Article Snippet: Single cell mRNA data for heart tissue were collected from the Human Protein Atlas (HPA) version 25.0 (release date: 11 November 2025) [ ].

    Techniques: Over Expression, Activation Assay, Expressing, MANN-WHITNEY